Analysis of the Influencing Factors of Tumor Volume, Body Immunity, and Poor Prognosis after ¹²⁵I Particle Therapy for Differentiated Thyroid Cancer

Table 4

Comparison of immune function .

Time	Groups	ALC (10^9/L)	NLR	LMR	PLR
Before treatment	Low-dose group ()
	High-dose group ()
t		0.116	0.096	0.398	0.488
		0.908	0.923	0.691	0.627
After treatment	Low-dose group ()	^a	^a	^a	^a
	High-dose group ()	^a	^a	^a	^a
t		1.222	3.597	3.473	3.747
		0.225	0.001	0.001	<0.001

Note: ^a compared with the same group before treatment; ALC: absolute lymphocyte count; NLR: neutrophil to lymphocyte ratio; LMR: lymphocyte to monocyte ratio; PLR: platelet to lymphocyte ration.